New submission process key to any pan-tumour change

October 2, 2018 Latest News

This is a preview of subscriber content

Subscribe now to continue reading.

The outcomes statement from the August special PBAC meeting reveals the committee largely sticking with the current approach and defaulting to the ongoing discussions on proposed submission process changes. …

Subscribe now to continue reading.

Latest Video

If this makes you uncomfortable, it should, because it is the only correct response
September 16, 2025 - Latest News
Merck welcomes new director of market access, government affairs and communications
September 16, 2025 - Latest News
Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms
September 19, 2025 - Latest News
Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand
September 16, 2025 - Latest News
If the minister is too embarrassed to respond, it might be the best of bad responses
September 19, 2025 - Latest News

New submission process key to any pan-tumour change

This is a preview of subscriber content

Latest Video

Most Read

If this makes you uncomfortable, it should, because it is the only correct response

Merck welcomes new director of market access, government affairs and communications

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand

If the minister is too embarrassed to respond, it might be the best of bad responses

New Stories

If the minister is too embarrassed to respond, it might be the best of bad responses

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

CSL appoints new global head of search to accelerate innovation through strategic partnerships

Pharmacy Guild of Australia acquires Member Benefits Australia

Sanofi promotes a national dialogue on health literacy and trust

Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies

Australian Dementia Network Registry wants access to 'turning point' therapies

Sign In

New submission process key to any pan-tumour change

This is a preview of subscriber content

Latest Video

Most Read

If this makes you uncomfortable, it should, because it is the only correct response

Merck welcomes new director of market access, government affairs and communications

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand

If the minister is too embarrassed to respond, it might be the best of bad responses

Follow Us

New Stories

If the minister is too embarrassed to respond, it might be the best of bad responses

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

CSL appoints new global head of search to accelerate innovation through strategic partnerships

Pharmacy Guild of Australia acquires Member Benefits Australia

Sanofi promotes a national dialogue on health literacy and trust

Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies

Australian Dementia Network Registry wants access to 'turning point' therapies